L. M. Azar Et Al. , "Human ACE2 orthologous peptide sequences show better binding affinity to SARS-CoV-2 RBD domain: Implications for drug design," COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL , vol.21, pp.4096-4109, 2023
Azar, L. M. Et Al. 2023. Human ACE2 orthologous peptide sequences show better binding affinity to SARS-CoV-2 RBD domain: Implications for drug design. COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL , vol.21 , 4096-4109.
Azar, L. M., Oncel, M. M., KARAMAN, E., Soysal, L. F., FATIMA, A., Choi, S. B., ... Eyupoglu, A. E.(2023). Human ACE2 orthologous peptide sequences show better binding affinity to SARS-CoV-2 RBD domain: Implications for drug design. COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL , vol.21, 4096-4109.
Azar, Lena Et Al. "Human ACE2 orthologous peptide sequences show better binding affinity to SARS-CoV-2 RBD domain: Implications for drug design," COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL , vol.21, 4096-4109, 2023
Azar, Lena M. Et Al. "Human ACE2 orthologous peptide sequences show better binding affinity to SARS-CoV-2 RBD domain: Implications for drug design." COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL , vol.21, pp.4096-4109, 2023
Azar, L. M. Et Al. (2023) . "Human ACE2 orthologous peptide sequences show better binding affinity to SARS-CoV-2 RBD domain: Implications for drug design." COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL , vol.21, pp.4096-4109.
@article{article, author={Lena Mahmoudi Azar Et Al. }, title={Human ACE2 orthologous peptide sequences show better binding affinity to SARS-CoV-2 RBD domain: Implications for drug design}, journal={COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL}, year=2023, pages={4096-4109} }